rs4143815-<i>PDL1</i>, a New Potential Immunogenetic Biomarker of Biochemical Recurrence in Locally Advanced Prostate Cancer after Radiotherapy
Up to 30−50% of patients with locally advanced prostate cancer (PCa) undergoing radiotherapy (RT) experience biochemical recurrence (BCR). The immune system affects the RT response. Immunogenetics could define new biomarkers for personalization of PCa patients’ treatment. The aim...
Main Authors: | Chiara Zanusso, Eva Dreussi, Roberto Bortolus, Chiara Romualdi, Sara Gagno, Elena De Mattia, Loredana Romanato, Franca Sartor, Luca Quartuccio, Erika Cecchin, Giuseppe Toffoli |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/9/2082 |
Similar Items
-
A Clinical-Genetic Score to Identify Surgically Resected Colorectal Cancer Patients Benefiting From an Adjuvant Fluoropyrimidine-Based Therapy
by: Elena De Mattia, et al.
Published: (2018-10-01) -
SIGNIFICANCE OF IMMUNOGENETIC PREDISPOSAL FOR CLINICAL COURSE OF MYASTHENIA
by: L. N. Bubnova, et al.
Published: (2014-07-01) -
An anthropological approach to immunogenetic variation in Manitoba First Nation populations: implications for tuberculosis
by: Decter, Kate Leah Una
Published: (2013) -
An anthropological approach to immunogenetic variation in Manitoba First Nation populations: implications for tuberculosis
by: Decter, Kate Leah Una
Published: (2013) -
The Immunogenetics of Psoriasis and Implications for Drug Repositioning
by: Xuan Xu, et al.
Published: (2017-12-01)